COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 4.00 |
| 52 Week High | 7.66 |
| 52 Week Low | 3.29 |
| Avg. Daily Vol. (Mil) | 1.23 |
| Beta (3 year) | 1.74 |
| Share Related Items | |
| Mkt Cap (Mil) | 313.29 |
| Shares Out (Mil) | 78.32 |
| Float (Mil) | 61.65 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.30 |
| Current Ratio | 3.70 |
| LT Debt/ Equity | 0.30 |
| Total Debt / Equity | 0.34 |
| Valuation Ratios | |
| Price Earnings | 7.70 |
| Price/Sales | 1.07 |
| Price/Book | 0.82 |
| Price/Cash Flow | 6.00 |
| Per Share Data | |
| Earnings | 0.52 |
| Sales | 3.73 |
| Book Value | 4.87 |
| Cash Flow | 0.67 |
| Business Summary | |
|---|---|
| A fully integrated pharmaceutical company dedicated to improving health through the development, manufacture, commercialization and distribution of a range of pharmaceutical and healthcare products in China. | |
| General Information | |
| 25th Floor,Great China INTL
Exchange Square,NO.1fuhua1RD Futian Dist.Shenzh, 518026 |
|
| 0.99999999718155 | |
| www.bioaobo.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 4076 | |
| CEO: Shujun (Tony) Liu | |
| Short Interest | |
| Current Month (Mil) | 11.39 |
| Previous Month (Mil) | 11.57 |
| Short Interest Ratio (Days) | 11.10 |
| Management Effectiveness | |
| Return on Equity | 10.30 |
| Return on Assets | 7.00 |
| Return on Investments | 7.90 |
| Profitability | |
| Gross Margin | 62.00 |
| EBIT Margin | 19.00 |
| Profit Margin | 13.40 |